Meyka AI API is live for developers.Start building.
Advertisement
Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. (CRDL) Stock Overview

Explore Cardiol Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRDL●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.04
$0.00(0.00%)
U.S. Market opens in 54h 46m
Advertisement

Cardiol Therapeutics Inc. (CRDL)

Meyka AI Score

Z

Key Financials

Market Cap119.9M
P/E Ratio-3.81
EPS (TTM)$-0.28
ROE-2.29%
Fundamental Analysis

AI Price Forecasts

1 Month$1.09
3 Months$1.69
1 Year Target$0.51

CRDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cardiol Therapeutics Inc. (CRDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.81 and a market capitalization of 119.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.95%
1-Month Change
-20.00%
3-Month Change
-6.31%
6-Month Change
4.72%
Year-to-Date (YTD) Change
9.04%
1-Year Change
-29.25%
3-Year Change
28.40%
5-Year Change
-56.67%
All-Time (Max) Change
-72.20%

Contact Information

https://www.cardiolrx.com
289 910 0850
2265 Upper Middle Road East, Oakville, ON, L6H 0G5

Company Facts

180 Employees
IPO DateJan 15, 2019
CountryCA
Actively Trading

Frequently Asked Questions